GL1X · GenesisL1 explorer

MolNFT v1 · #145213 · protein

Crystal structure of a Fc fragment lala mutant (L234A, L235A) of human IGG1 (crystal form 1)

6CHF · Uncharacterized protein DKFZP686C11235: “Crystal structure of a Fc fragment lala mutant (L234A, L235A) of human IGG1 (crystal form 1)”. X-ray diffraction, 4 ligands (NAG, MAN, BMA), 2 pockets (best druggability 0.33). MolNFT v1…

PDB
6CHF
Type
protein
Length
419 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Uncharacterized protein DKFZP686C11235
UniProt
Q6MZV7
Ligands
NAG, MAN, BMA, FUC
Pockets
2 · best druggability 0.33

Structure

x-ray diffraction · 2 distinct chains · 11% helix, 47% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AUncharacterized protein DKFZP686C11235protein21111% helix, 47% strandQ6MZV7
BUncharacterized protein DKFZP686C11235protein20811% helix, 46% strandQ6MZV7

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 8 copies · chains A, B
  • MAN · alpha-D-mannopyranose · sugar · 4 copies · chains A, B
  • BMA · beta-D-mannopyranose · sugar · 2 copies · chains A, B
  • FUC · alpha-L-fucopyranose · sugar · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1810.330.7517empty
2570.290.7517empty

Interfaces

1 interface between chains.

  • A–B · 1174 Ų buried · 9 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide, 2 glycan (disulfide, N-glycosylation).

Compared structures

  • 6CHF · Crystal structure of a Fc fragment LALA mutant (L234A, L235A) of human IgG1 (crystal form… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.